Evidence map›Paper›PMID 29213084›Full record

ArticleScientific reports2017

Emerging Role for the PERK/eIF2α/ATF4 in Human Cutaneous Leishmaniasis.

Karina Luiza Dias-Teixeira, Teresa C Calegari-Silva, Jorge M Medina, Áislan C Vivarini, Átila Cavalcanti, Nataly Teteo, Alynne Karen M Santana, Fernando Real, Ciro M Gomes, Renata Meirelles Santos Pereira and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 34 citations in OpenAlex.

  1. Infection and immunity · 2026
    Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Proteome profiling of cutaneous leishmaniasis lesions due to dermotropicbioRxiv : the preprint server for biology · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Karina Luiza Dias-TeixeiraLaboratory of Molecular Parasitology, Institute of Biophysics - Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil.
Teresa C Calegari-SilvaLaboratory of Molecular Parasitology, Institute of Biophysics - Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil.
Jorge M MedinaInstitute of Medical Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil.
Áislan C VivariniLaboratory of Molecular Parasitology, Institute of Biophysics - Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil.
Átila CavalcantiLaboratory of Molecular Parasitology, Institute of Biophysics - Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil.
Nataly TeteoLaboratory of Molecular Parasitology, Institute of Biophysics - Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil.
Alynne Karen M SantanaDepartment of Biochemistry and Immunology - University of São Paulo, Ribeirão Preto, SP 14049-900, Brazil.
Fernando RealDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, SP 04023-062, Brazil.ORCID 0000-0002-5060-4334
Ciro M GomesFaculty of Medicine, University of Brasília, Brasília, DF 70910-900, Brazil.ORCID 0000-0002-3069-6884
Renata Meirelles Santos PereiraInstituto de Microbiologia Paulo de Goes, Federal University of Rio de Janeiro, 21942-902, Rio de Janeiro, Brazil.
Nicolas FaselCenter for Immunity and Infection Lausanne, Department of Biochemistry, Faculty of Biology and Medicine, University of Lausanne, CH-1066, Epalinges, Switzerland.
João S SilvaDepartment of Biochemistry and Immunology - University of São Paulo, Ribeirão Preto, SP 14049-900, Brazil.
Bertal H AktasHematology Laboratory for Translation, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, United States.
Ulisses G LopesLaboratory of Molecular Parasitology, Institute of Biophysics - Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21949-902, Brazil. lopesu@biof.ufrj.br.
Universidade Federal do Rio de Janeiro · BRUniversidade de São Paulo · BRBrigham and Women's Hospital · USUniversidade de Brasília · BRUniversidade Federal de São Paulo · BRUniversity of Lausanne · CH

Funding

Targeting Endoplasmic Reticulum Stress Response for Cancer TherapyR01CA152312 · NCI · HARVARD MEDICAL SCHOOL · PI AKTAS, BERTAL H. · 2011 to 2015
$1.8M
NCI NIH HHS R01 CA152312
6 · The paper itself

Abstract

Leishmania parasites utilize adaptive evasion mechanisms in infected macrophages to overcome host defenses and proliferate. We report here that the PERK/eIF2α/ATF4 signaling branch of the integrated endoplasmic reticulum stress response (IERSR) is activated by Leishmania and this pathway is important for Leishmania amazonensis infection. Knocking down PERK or ATF4 expression or inhibiting PERK kinase activity diminished L. amazonensis infection. Knocking down ATF4 decreased NRF2 expression and its nuclear translocation, reduced HO-1 expression and increased nitric oxide production. Meanwhile, the increased expression of ATF4 and HO-1 mRNAs were observed in lesions derived from patients infected with the prevalent related species L.(V.) braziliensis. Our data demonstrates that Leishmania parasites activate the PERK/eIF2α/ATF-4 pathway in cultured macrophages and infected human tissue and that this pathway is important for parasite survival and progression of the infection.

Indexed as

Activating Transcription Factor 4AnimalsEndoplasmic Reticulum StressEukaryotic Initiation Factor-2HEK293 CellsHeme Oxygenase-1HumansLeishmaniaLeishmaniasis, CutaneousMacrophagesMiceMice, Inbred C57BLNF-E2-Related Factor 2Nitric OxidePhosphorylationRAW 264.7 CellsActivating Transcription Factor 4ATF4 protein, humanEukaryotic Initiation Factor-2Heme Oxygenase-1NF-E2-Related Factor 2Nitric OxideRNA, Small Interfering

Identifiers

PMID29213084
PMCPMC5719050
OpenAlexW2774227589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.